title: Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis.
abstract: Of the multiple sources of reactive oxygen species (ROS) in the blood vessel, NADPH oxidases are the primary source. Whereas several studies have implicated NADPH oxidases in the initiation of atherosclerosis, their roles in disease progression are incompletely understood. Our objective was to determine the potential clinical relevance of inhibiting NADPH oxidase in established atherosclerosis. Using a hypercholesteremic murine model of atherosclerosis (ApoE-/-/LDLR-/- (AS) mice on normal chow diet), we first established a time-dependent relationship between superoxide levels and lesion size in AS mice. Next, we identified NADPH oxidase as the primary source of ROS in atherosclerotic lesions. Treatment of aortic segments from AS mice with apocynin, which interferes with NADPH oxidase activation in part by preventing translocation of the subunit p47phox, significantly reduced superoxide levels. Moreover, addition of apocynin to the drinking water of AS mice produced a decrease in lesion size as compared to untreated AS mice, with the effect most pronounced in the thoracoabdominal aorta but absent from the aortic arch. Granulocyte function in AS+apocynin mice was suppressed, confirming efficacy of apocynin treatment. We conclude that apocynin attenuates the progression of atherosclerosis in hypercholesterolemic mice, potentially by its ability to inhibit generation of superoxide by NADPH oxidase.
authors: Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA. kara.seaton@hotmail.com
authors: Kara
authors: K
authors: Kinkade
authors: Jennifer
authors: J
authors: Streeter
authors: Francis J
authors: FJ
authors: Miller
mesh_terms: D000098:Acetophenones / Q000494:pharmacology*; D000818:Animals; D001012:Aorta, Abdominal / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D050197:Atherosclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D005260:Female; D006937:Hypercholesterolemia / Q000201:enzymology; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D021381:Protein Transport; D016897:Respiratory Burst / Q000187:drug effects; D013481:Superoxides / Q000378:metabolism
chemical_list: D000098:Acetophenones; D013481:Superoxides; C056165:acetovanillone; D019255:NADPH Oxidases; C060505:neutrophil cytosolic factor 1
references: Am J Physiol Heart Circ Physiol. 2010 Jan;298(1):H24-32
references: 19837950
references: PLoS One. 2012;7(12):e50767
references: 23251382
references: Free Radic Biol Med. 2004 Jul 15;37(2):156-65
references: 15203187
references: J Vasc Res. 2012;49(3):242-8
references: 22433789
references: Atherosclerosis. 2011 Jun;216(2):321-6
references: 21411092
references: Circulation. 2006 Aug 1;114(5):404-413
references: 16864727
references: Circ Res. 2002 Feb 22;90(3):277-83
references: 11861415
references: Circulation. 2013 May 7;127(18):1888-902
references: 23564668
references: J Neurosci. 2008 Nov 12;28(46):12039-51
references: 19005069
references: Circulation. 1999 Oct 5;100(14):1494-8
references: 10510050
references: Free Radic Biol Med. 2010 Jun 15;48(12):1636-43
references: 20304045
references: Circulation. 2000 Mar 21;101(11):1234-6
references: 10725280
references: J Pediatr. 1973 Jul;83(1):77-82
references: 4768939
references: Circulation. 2002 Mar 26;105(12):1429-35
references: 11914250
references: Cardiovasc Res. 2012 Apr 1;94(1):20-9
references: 22287576
references: Biochem Biophys Res Commun. 2013 Feb 8;431(2):124-30
references: 23318172
references: Hypertension. 2008 Feb;51(2):211-7
references: 18086956
references: J Clin Invest. 2001 Nov;108(10):1513-22
references: 11714743
references: Am J Respir Cell Mol Biol. 1994 Jul;11(1):95-102
references: 8018341
references: J Biol Chem. 2003 Feb 7;278(6):3510-3
references: 12473664
references: Circ Res. 2012 May 11;110(10):1364-90
references: 22581922
references: J Am Coll Cardiol. 2008 Nov 25;52(22):1803-9
references: 19022160
references: Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):333-9
references: 16293794
references: Endothelium. 2002;9(3):191-203
references: 12380644
references: Cardiovasc Ther. 2013 Jun;31(3):125-37
references: 22280098
references: J Drug Target. 2012 Aug;20(7):605-14
references: 22738345
references: Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1529-35
references: 10845868
references: Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2714-21
references: 17823367
references: Circ Res. 1998 Jun 29;82(12):1298-305
references: 9648726
references: Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):560-5
references: 11950691
references: Cardiovasc Res. 2012 Jul 1;95(1):116-23
references: 22547655
references: Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):653-61
references: 19910640
references: Nat Rev Drug Discov. 2011 Jun;10(6):453-71
references: 21629295
references: Scand J Immunol. 1996 Mar;43(3):329-34
references: 8602468